Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,611.83
(
0.00%
)
US TECH 100
23,398.40
(
-0.60%
)
Dow Jones
46,669.88
(
0.00%
)
Brent Oil
107.34
(
0.25%
)
Bitcoin
68,480.13
(
-0.55%
)
News Focus
News Focus
Post# of 74
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Golden Cross

Send PM Follow Ignore
Followers 3392
Posts 100822
Boards Moderated 9
Alias Born 10/05/2005

Golden Cross

Member Level

Re: Golden Cross post# 3

Saturday, 06/27/2020 12:17:34 AM

Saturday, June 27, 2020 12:17:34 AM

Post# of 74
Xeris Pharmaceuticals (NASDAQ:XERS) Cut to "Hold" at Zacks Investment Research
6/23/20, 03:32 AM - Ticker Report
Summary
Zacks Investment Research lowered shares of Xeris Pharmaceuticals (NASDAQ:XERS) from a buy rating to a hold rating in a research report released on Saturday morning, Zacks.com reports. Zacks Investment Research currently has $5.75 target price on the stock. According to Zacks, Xeris ...

Give Me A Follow If You Want To Consistently Find Winners!

Click Here:
https://investorshub.advfn.com/boards/profilea.aspx?user=61470

Please do your own DD...All my posts are my opinion only!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent XERS News
More XERS News